Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CTLA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CFAP74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724884 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRSK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC554206 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DGCR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POM121L10P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100272217 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on